Yoshio Sumida

11.9k total citations · 3 hit papers
181 papers, 7.4k citations indexed

About

Yoshio Sumida is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Yoshio Sumida has authored 181 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Epidemiology, 76 papers in Hepatology and 49 papers in Surgery. Recurrent topics in Yoshio Sumida's work include Liver Disease Diagnosis and Treatment (127 papers), Diet, Metabolism, and Disease (38 papers) and Liver Disease and Transplantation (34 papers). Yoshio Sumida is often cited by papers focused on Liver Disease Diagnosis and Treatment (127 papers), Diet, Metabolism, and Disease (38 papers) and Liver Disease and Transplantation (34 papers). Yoshio Sumida collaborates with scholars based in Japan, United States and Singapore. Yoshio Sumida's co-authors include Masashi Yoneda, Takeshi Okanoue, Yoshito Itoh, Yuichiro Eguchi, Atsushi Nakajima, Hideyuki Hyogo, Masafumi Ono, Masato Yoneda, Hironori Mitsuyoshi and Kazuyuki Kanemasa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Yoshio Sumida

170 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

2015 598 citations Kento Imajo, Masato Yoneda et al. profile →
Current and future pharmacological therapies for NAFLD/NASH

2017 522 citations Yoshio Sumida, Masashi Yoneda Journal of Gastroenterology profile →
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

2014 496 citations Yoshio Sumida profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshio Sumida Japan	42	5.8k	2.9k	2.3k	1.2k	1.2k	181	7.4k
Per Stål Sweden	35	6.0k 1.0×	3.6k 1.2×	2.2k 0.9×	948 0.8×	825 0.7×	135	7.7k
Yuichiro Eguchi Japan	40	4.8k 0.8×	3.0k 1.0×	1.6k 0.7×	1.0k 0.8×	981 0.8×	178	6.7k
Sven Francque Belgium	48	7.3k 1.3×	3.2k 1.1×	2.9k 1.2×	1.5k 1.2×	1.5k 1.3×	194	9.1k
Mariana Verdelho Machado Portugal	36	4.9k 0.8×	1.8k 0.6×	1.9k 0.8×	927 0.8×	2.1k 1.8×	90	6.7k
Bilal Hameed United States	24	4.1k 0.7×	2.5k 0.8×	1.3k 0.6×	1.2k 1.0×	857 0.7×	70	5.7k
Edward Doo United States	26	5.2k 0.9×	3.7k 1.3×	1.3k 0.6×	1.2k 1.0×	868 0.8×	42	6.7k
Coleman I. Smith United States	21	7.9k 1.4×	6.6k 2.3×	1.5k 0.7×	673 0.6×	1.0k 0.9×	55	9.8k
Takuji Torimura Japan	45	3.4k 0.6×	3.3k 1.1×	1.2k 0.5×	1.4k 1.1×	1.7k 1.5×	282	7.6k
Marcello Persico Italy	41	4.3k 0.7×	3.3k 1.1×	987 0.4×	803 0.7×	716 0.6×	204	6.5k
Carolin Lackner Austria	41	2.9k 0.5×	1.5k 0.5×	1.5k 0.6×	2.4k 2.0×	1.6k 1.4×	98	7.6k

Countries citing papers authored by Yoshio Sumida

Since Specialization

Citations

This map shows the geographic impact of Yoshio Sumida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Sumida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Sumida more than expected).

Fields of papers citing papers by Yoshio Sumida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Sumida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Sumida. The network helps show where Yoshio Sumida may publish in the future.

Co-authorship network of co-authors of Yoshio Sumida

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Sumida. A scholar is included among the top collaborators of Yoshio Sumida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Sumida. Yoshio Sumida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kamada, Yoshihiro, et al.. (2024). Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review. Journal of Gastroenterology. 60(1). 10–23.

Kumada, Takashi, Hidenori Toyoda, Sadanobu Ogawa, et al.. (2024). Diagnostic performance of shear wave measurement in the detection of hepatic fibrosis: A multicenter prospective study. Hepatology Research. 54(9). 851–858. 2 indexed citations

Kumada, Takashi, Hidenori Toyoda, Sadanobu Ogawa, et al.. (2024). Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction–associated steatotic liver disease. Liver International. 44(7). 1700–1714. 2 indexed citations

Hashida, Ryuki, Dan Nakano, Hiroo Matsuse, et al.. (2023). A low‐intensity 10‐min resistance exercise program that ameliorated hepatic fibrosis indices and altered G‐CSF/IP‐10/PDGF‐BB in a patient with nonalcoholic fatty liver disease: A case report. JGH Open. 7(3). 231–234. 2 indexed citations

Miura, Kouichi, Hideki Hayashi, Yoshihiro Kamada, et al.. (2023). Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver‐related events in nonalcoholic fatty liver disease. Hepatology Research. 53(10). 978–988. 12 indexed citations

Hayashi, Hideki, Yoshihiro Kamada, Hideki Fujii, et al.. (2023). Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology. 49(7). 1658–1664. 6 indexed citations

Kumada, Takashi, Hidenori Toyoda, Satoshi Yasuda, et al.. (2022). Combined ultrasound and magnetic resonance elastography predict hepatocellular carcinoma after hepatitis C virus eradication. Hepatology Research. 52(11). 957–967. 6 indexed citations

Sugiyama, Hiroki, Yukio Kobayashi, Sayori Wada, et al.. (2022). An examination of eating behavior in patients with non-alcoholic fatty liver disease: A cross-sectional study in a Japanese population. SHILAP Revista de lepidopterología. 28. 200150–200150. 1 indexed citations

Kamada, Yoshihiro, Takashi Nakahara, Kensuke Munekage, et al.. (2022). Serum Mac‐2 binding protein level predicts the development of liver‐related events and colorectal cancer in patients with NAFLD. Hepatology Communications. 6(7). 1527–1536. 4 indexed citations

10.

Inoue, Tadahisa, Itaru Naitoh, Rena Kitano, et al.. (2022). Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma. Current Oncology. 29(4). 2240–2251. 14 indexed citations

11.

Kamada, Yoshihiro, Kensuke Munekage, Takashi Nakahara, et al.. (2022). The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD. Nutrients. 15(1). 66–66. 20 indexed citations

12.

Sumida, Yoshio, Masashi Yoneda, Katsutoshi Tokushige, et al.. (2021). FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic. Life. 11(2). 143–143. 39 indexed citations

13.

Kamada, Yoshihiro, Hirokazu Takahashi, Masahito Shimizu, et al.. (2021). Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review. Journal of Gastroenterology. 56(12). 1045–1061. 28 indexed citations

14.

Eguchi, Yuichiro, et al.. (2020). Hepatocellular carcinoma and other complications of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A structured review of published works. Hepatology Research. 51(1). 19–30. 21 indexed citations

15.

Toyoda, Hidenori, Satoshi Yasuda, Seiki Kiriyama, et al.. (2020). Impact of COVID‐19 pandemic on surveillance of hepatocellular carcinoma: A study in patients with chronic hepatitis C after sustained virologic response. PubMed. 2(5). 247–252. 8 indexed citations

16.

Yamamura, Sakura, Dan Nakano, Ryuki Hashida, et al.. (2020). Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology. 36(3). 629–636. 26 indexed citations

17.

Eguchi, Yuichiro, et al.. (2020). Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review. Hepatology Research. 50(6). 645–655. 13 indexed citations

18.

Sumida, Yoshio, Masashi Yoneda, Katsutoshi Tokushige, et al.. (2020). Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 21(6). 1907–1907. 50 indexed citations

19.

Sumida, Yoshio, Masashi Yoneda, Yuya Seko, et al.. (2020). Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Diagnostics. 10(8). 579–579. 23 indexed citations

20.

Sumida, Yoshio, Toshihide Shima, Yasuhide Mitsumoto, et al.. (2020). Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan. International Journal of Molecular Sciences. 21(12). 4337–4337. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact